Skip to main content

Adriamycin-induced senescence in breast tumor cells involves functional p53 and telomere dysfunction.

Publication ,  Journal Article
Elmore, LW; Rehder, CW; Di, X; McChesney, PA; Jackson-Cook, CK; Gewirtz, DA; Holt, SE
Published in: J Biol Chem
September 20, 2002

Direct experimental evidence implicates telomere erosion as a primary cause of cellular senescence. Using a well characterized model system for breast cancer, we define here the molecular and cellular consequences of adriamycin treatment in breast tumor cells. Cells acutely exposed to adriamycin exhibited an increase in p53 activity, a decline in telomerase activity, and a dramatic increase in beta-galactosidase, a marker of senescence. Inactivation of wild-type p53 resulted in a transition of the cellular response to adriamycin treatment from replicative senescence to delayed apoptosis, demonstrating that p53 plays an integral role in the fate of breast tumor cells treated with DNA-damaging agents. Stable introduction of hTERT, the catalytic protein component of telomerase, into MCF-7 cells caused an increase in telomerase activity and telomere length. Treatment of MCF-7-hTERT cells with adriamycin produced an identical senescence response as controls without signs of telomere shortening, indicating that the senescence after treatment is telomere length-independent. However, we found that exposure to adriamycin resulted in an overrepresentation of cytogenetic changes involving telomeres, showing an altered telomere state induced by adriamycin is probably a causal factor leading to the senescence phenotype. To our knowledge, these data are the first to demonstrate that the mechanism of adriamycin-induced senescence is dependent on both functional p53 and telomere dysfunction rather than overall shortening.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Biol Chem

DOI

ISSN

0021-9258

Publication Date

September 20, 2002

Volume

277

Issue

38

Start / End Page

35509 / 35515

Location

United States

Related Subject Headings

  • Tumor Suppressor Protein p53
  • Tumor Cells, Cultured
  • Telomere
  • Telomerase
  • Reverse Transcriptase Polymerase Chain Reaction
  • In Situ Nick-End Labeling
  • Humans
  • Doxorubicin
  • Cellular Senescence
  • Breast Neoplasms
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Elmore, L. W., Rehder, C. W., Di, X., McChesney, P. A., Jackson-Cook, C. K., Gewirtz, D. A., & Holt, S. E. (2002). Adriamycin-induced senescence in breast tumor cells involves functional p53 and telomere dysfunction. J Biol Chem, 277(38), 35509–35515. https://doi.org/10.1074/jbc.M205477200
Elmore, Lynne W., Catherine W. Rehder, Xu Di, Patricia A. McChesney, Colleen K. Jackson-Cook, David A. Gewirtz, and Shawn E. Holt. “Adriamycin-induced senescence in breast tumor cells involves functional p53 and telomere dysfunction.J Biol Chem 277, no. 38 (September 20, 2002): 35509–15. https://doi.org/10.1074/jbc.M205477200.
Elmore LW, Rehder CW, Di X, McChesney PA, Jackson-Cook CK, Gewirtz DA, et al. Adriamycin-induced senescence in breast tumor cells involves functional p53 and telomere dysfunction. J Biol Chem. 2002 Sep 20;277(38):35509–15.
Elmore, Lynne W., et al. “Adriamycin-induced senescence in breast tumor cells involves functional p53 and telomere dysfunction.J Biol Chem, vol. 277, no. 38, Sept. 2002, pp. 35509–15. Pubmed, doi:10.1074/jbc.M205477200.
Elmore LW, Rehder CW, Di X, McChesney PA, Jackson-Cook CK, Gewirtz DA, Holt SE. Adriamycin-induced senescence in breast tumor cells involves functional p53 and telomere dysfunction. J Biol Chem. 2002 Sep 20;277(38):35509–35515.

Published In

J Biol Chem

DOI

ISSN

0021-9258

Publication Date

September 20, 2002

Volume

277

Issue

38

Start / End Page

35509 / 35515

Location

United States

Related Subject Headings

  • Tumor Suppressor Protein p53
  • Tumor Cells, Cultured
  • Telomere
  • Telomerase
  • Reverse Transcriptase Polymerase Chain Reaction
  • In Situ Nick-End Labeling
  • Humans
  • Doxorubicin
  • Cellular Senescence
  • Breast Neoplasms